brand positioning

Recent Articles

• Case Study : Rituxan – A Brand which Pharma Industry reckon
• In which class should be register the food supplement?
• Cipla’s JV with Jiangsu Acebright Pharma in China
• US FDA grants priority review status to Novartis’ sickle cell molecule crizanlizumab
• Case Study: Gilead and Galapagos – R&D collaboration
• How data integrity related problems should be addressed in Pharmaceutical and Biopharmaceutical Industry?
• AstraZeneca’s Forxiga gets EMA positive opinion for DECLARE-TIMI 58 cardiovascular outcomes data
• US FDA warning letter: Repackers distributing API for violations of cGMP violation requirements
• Gilead introduces Asia Pacific Rainbow Grants program
• Case Study: EC’s conditional marketing approval to Libtayo for advanced CSCC
• What is Conditional marketing authorisation by European Medicine Agency?
• List of USFDA approved Biosimilar [till date]
• US FDA approves Pfizer’s Biosimilar Zirabev
• What is USFDA Tentative Approval?
• Case Analysis: Insight on AbbVie’s acquisition of Allergan
• Glenmark’s licensing deal with Novartis to distribute three respiratory drugs in Brazil
• What is CRL – Complete Response Letter by USFDA?
• Case Study: Vyleesi™ (Bremelanotide Injection) for HSDD in Premenopausal Women
• FDA Approval of sNDA for DEXTENZA for the Treatment of Ocular Inflammation Following Ophthalmic Surgery
• A triple-combination therapy for COPD – Breztri Aerosphere’s of AstraZeneca received approval in Japan